AntiCancer Inc.

Vion Pharmaceuticals Files for Chapter 11 Bankruptcy.
Blood Weekly; 12/31/2009; 1151 words; ...VION PHARMACEUTICALS, INC. (BULLETIN BOARD...Vion Pharmaceuticals, Inc.). "We believe that...randomized trial of its lead anticancer compound, Onrigin...vionpharm.com. Keywords: Anticancer Therapy, Biotechnology...Vion Pharmaceuticals Inc. This article was prepared...

Journal Describes Mechanism Of Cyclacel's Seliciclib.
Investrend; 12/31/2009; 1349 words; ...FinancialWire) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP...Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs" was published in the online...NYSE: WFT), UQM Technologies, Inc. (AMEX: UQM), Panhandle Oil and...

ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting.
Blood Weekly; 12/31/2009; 1091 words; ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced...also ARIAD Pharmaceuticals, Inc.). The primary objectives...treatment options." Keywords: Anticancer Therapy, Antitumor Activity, Ariad Pharmaceuticals Inc., Biotechnology, Cancer...

Studies from Shandong University reveal new findings on matrix metalloproteinase.(Report)
Biotech Week; 12/30/2009; 874 words; ...metalloproteinase-2(MMP-2) as anticancer agents, a three-dimensional quantitative...Chemistry Research is: Birkhauser Boston Inc., 675 Massachusetts Avenue, Cambridge...Country:People's Republic of China, Anticancer Therapy, Enzymes, Enzymology, Matrix...

OTCMarketbulls.com Reports Hot Market Movers For December 30, 2009 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) +39.58%, Luna Innovations Incorporated (NASDAQ: LUNA) +26.97%, SKRM Interactive, Inc. (OTCBB: SECI) +67.86%,.
M2 Presswire; 12/30/2009; 2569 words; ...Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) +39.58...97%, SKRM Interactive, Inc. (OTCBB: SECI) +67.86...Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq...Dependent Kinase Inhibitors as Anticancer Drugs" was published in the...